| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO
1 company
Kintz Samuel is a President And CEO at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $40.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 8,026 | $13.08 | $104,999.34 | -100% | +26.5% | +112.5% | |
| Sep 25, 2023 | ELVN Enliven Therapeutics, Inc. | President And CEO | Sale+OE | 12,000 | $13.81 | $165,691.20 | -100% | +4.3% | +73.3% |